Carlota Mendonça, Diana de Macedo, Carlos Nicolai, Hugo Madeira, Eric Van Dooren, David Norré, António Mata
{"title":"Digital Full-Arch Implant-Supported Polymethyl Methacrylate Interim Prosthesis: A Practice-Based Cohort Study on Survival and Quality of Life.","authors":"Carlota Mendonça, Diana de Macedo, Carlos Nicolai, Hugo Madeira, Eric Van Dooren, David Norré, António Mata","doi":"10.11607/ijp.8468","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the clinical survival and impact on oral health-related quality of life (OHRQoL) of immediate loading of implant-supported full-arch CAD/CAM-milled PMMA interim restorations.</p><p><strong>Materials and methods: </strong>This was a practice-based prospective cohort study performed in a Portuguese dental clinic. Eleven patients received a total of 17 CAD/CAM fully implant-supported, screw-retained, full-arch restorations with milled PMMA and were followed up for 1 year. The primary outcome was prosthesis survival, determined with a modification of the California Dental Association score and a Kaplan-Meier survival function analysis. The secondary outcome was the patient quality of life, as defined by application of the OHIP-14-PT questionnaire and standardized effect size variation between two visits. Significance was set at 5%.</p><p><strong>Results: </strong>Survival probability at 12 months was 76%, complete fracture of the prosthesis occurred in 17.6% of the cases, and small fractures without lab involvement occurred in 5.9% of cases. There was a significant improvement in OHRQoL between visit 1 and visit 4. The mean difference and effect size for total OHIP-14-PT score were -32.91 ± 3.68 and 3.66 (95% CI -1.83 to -5.80) respectively (P < .001* Wilcoxon matched paired rank test).</p><p><strong>Conclusions: </strong>Fullarch implant-supported CAD/CAM-milled PMMA interim prosthesis seem to be a viable approach with good survival rate and great impact on patient OHRQoL.</p>","PeriodicalId":94232,"journal":{"name":"The International journal of prosthodontics","volume":"0 0","pages":"394-403"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The International journal of prosthodontics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11607/ijp.8468","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: To evaluate the clinical survival and impact on oral health-related quality of life (OHRQoL) of immediate loading of implant-supported full-arch CAD/CAM-milled PMMA interim restorations.
Materials and methods: This was a practice-based prospective cohort study performed in a Portuguese dental clinic. Eleven patients received a total of 17 CAD/CAM fully implant-supported, screw-retained, full-arch restorations with milled PMMA and were followed up for 1 year. The primary outcome was prosthesis survival, determined with a modification of the California Dental Association score and a Kaplan-Meier survival function analysis. The secondary outcome was the patient quality of life, as defined by application of the OHIP-14-PT questionnaire and standardized effect size variation between two visits. Significance was set at 5%.
Results: Survival probability at 12 months was 76%, complete fracture of the prosthesis occurred in 17.6% of the cases, and small fractures without lab involvement occurred in 5.9% of cases. There was a significant improvement in OHRQoL between visit 1 and visit 4. The mean difference and effect size for total OHIP-14-PT score were -32.91 ± 3.68 and 3.66 (95% CI -1.83 to -5.80) respectively (P < .001* Wilcoxon matched paired rank test).
Conclusions: Fullarch implant-supported CAD/CAM-milled PMMA interim prosthesis seem to be a viable approach with good survival rate and great impact on patient OHRQoL.